Dr. Melinda Gooderham is a distinguished dermatologist and medical director at the SKiN Centre for Dermatology in Peterborough, Ontario, where she leads cutting-edge clinical research and patient care initiatives. She maintains a multifaceted academic appointment as an Assistant Professor at Queen's University, contributing significantly to the education of medical students and residents through both didactic instruction and hands-on clinical training. Dr. Gooderham earned her Bachelor of Science degree from Queen's University in 1992, followed by a Master of Science from the University of Guelph in 1995, and completed her medical degree at the University of Western Ontario in 1999. She further refined her expertise through dermatology residency training at the University of Toronto, completing her program in 2004 and establishing herself as a board-certified dermatologist through the Royal College of Physicians and Surgeons of Canada.
Dr. Gooderham has established herself as a leading investigator in inflammatory skin diseases, having participated in over 220 clinical trials focusing on psoriasis, atopic dermatitis, hidradenitis suppurativa, alopecia areata, and vitiligo. Her extensive scholarly contributions include authorship of more than 210 peer-reviewed articles, where she serves as both author and reviewer for prestigious dermatology publications. Her research has significantly advanced therapeutic approaches for chronic inflammatory skin conditions, particularly through her work evaluating novel biologic therapies and treatment protocols that have transformed patient management strategies. As a consultant physician at the Peterborough Regional Health Centre, she bridges the gap between clinical research and practical application, ensuring that the latest evidence-based treatments reach patients in real-world settings.
Beyond her clinical and research activities, Dr. Gooderham actively shapes the global dermatology community through her leadership roles with the International Eczema Council and International Psoriasis Council, where she contributes to developing international treatment guidelines and educational initiatives. She shares her expertise internationally through engaging lectures on innovative therapies for skin diseases, influencing clinical practice worldwide and mentoring the next generation of dermatologists. As an investigator with Probity Medical Research, she continues to drive forward clinical investigation in dermatology, focusing on optimizing treatment outcomes for patients with complex skin conditions. Her ongoing commitment to advancing dermatological care through rigorous research, clinical excellence, and educational leadership positions her as a pivotal figure in the continued evolution of evidence-based dermatology practice.
